CN103007188A - Pharmaceutical composition for treating gallstone - Google Patents

Pharmaceutical composition for treating gallstone Download PDF

Info

Publication number
CN103007188A
CN103007188A CN 201210467512 CN201210467512A CN103007188A CN 103007188 A CN103007188 A CN 103007188A CN 201210467512 CN201210467512 CN 201210467512 CN 201210467512 A CN201210467512 A CN 201210467512A CN 103007188 A CN103007188 A CN 103007188A
Authority
CN
China
Prior art keywords
parts
radix
pharmaceutical composition
bowl
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201210467512
Other languages
Chinese (zh)
Inventor
董德华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201210467512 priority Critical patent/CN103007188A/en
Publication of CN103007188A publication Critical patent/CN103007188A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a pharmaceutical composition for treating gallstone, which is characterized by being prepared from the following raw materials in parts by weight: 20-40 parts of nutgrass galingale rhizome, 5-15 parts of costus root, 20-40 parts of curcuma root, 5-15 parts of white peony root, 10-20 parts of roasted licorice, 20-40 parts of achyranthes root, 5-15 parts of pinellia tuber, 20-40 parts of officinal magnolia bark, 30-40 parts of bupleurum and 10-30 parts of cape jasmine. A preparation method of the pharmaceutical composition comprises the following steps of: adding all raw materials into 1000ml of water for boiling, cooking with soft fire until 800ml of water is left, and then pouring the medical juice into a bowl; adding water into a medical pan until the water level is higher than the raw materials, cooking for 20 minutes, and then pouring the medical juice into the bowl; adding water into the medical pan until the water level is higher than the raw materials, cooking for 10 minutes, and then pouring the medical juice into the bowl; and mixing and uniformly stirring the medical juices poured three times to obtain the pharmaceutical composition. When in use, about 20-30ml of the pharmaceutical composition provided by the invention is taken with warm water every time and is taken three times per day. The pharmaceutical composition provided by the invention is reasonable in compatibility of medicines and convenient to take, has the functions of soothing the liver and regulating the flow of qi, nourishing the gallbladder and harmonizing the stomach as well as promoting flow of qi and blood circulation, and has an obvious effect on treating gallstone.

Description

The pharmaceutical composition for the treatment of cholelithiasis
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly a kind of pharmaceutical composition for the treatment of cholelithiasis.
Background technology
People's bile is obstructed, can cause drug concentration in bile to strengthen, and long-term bile is obstructed can to produce calculus, and cholelithiasis can make the patient produce dyspepsia, abdominal part distending pain, xerostomia, jaundice etc.
Summary of the invention
Technical problem to be solved by this invention is for the deficiencies in the prior art, and the pharmaceutical composition of the treatment cholelithiasis that a kind of compatibility is reasonable, therapeutic effect is good is provided.
Technical problem to be solved by this invention is to realize by following technical scheme, and the present invention is a kind of pharmaceutical composition for the treatment of cholelithiasis, is characterized in, it is to be made by the raw material of following weight proportion:
Rhizoma Cyperi 20-40; Radix Aucklandiae 5-15;
Radix Curcumae 20-40; Radix Paeoniae Alba 5-15;
Radix Glycyrrhizae Preparata 10-20; Radix Achyranthis Bidentatae 20-40;
Rhizoma Pinelliae 5-15; Cortex Magnoliae Officinalis 20-40;
Radix Bupleuri 30-40; Fructus Gardeniae 10-30;
During preparation, all raw materials are added water 1000ml boil, when transferring slow fire to and continuing to boil to 800ml medicine juice is poured in the bowl; Add water in the medicine pot and do not have raw material to continue to boil 20 minutes, medicine juice is poured in the bowl; Add water in the medicine pot and do not have raw material to continue to boil 10 minutes, medicine juice is poured in the bowl, the medicine juice of pouring out for three times is mixed stirring evenly, and get final product.
Technical problem to be solved by this invention can also further realize by following technical scheme, above-described a kind of pharmaceutical composition for the treatment of cholelithiasis, and the weight proportion of each raw material is:
Rhizoma Cyperi 30; The Radix Aucklandiae 10;
Radix Curcumae 30; The Radix Paeoniae Alba 10;
Radix Glycyrrhizae Preparata 15; Radix Achyranthis Bidentatae 30;
The Rhizoma Pinelliae 10; Cortex Magnoliae Officinalis 30;
Radix Bupleuri 350; Fructus Gardeniae 20.
During use, get about the present invention 20~30ml decoction being taken warmly, every day 3 times at every turn.
Compared with prior art, compatibility of the present invention is reasonable, taking convenience, and depressed liver-energy dispersing and QI regulating, function of gallbladder promoting stomach function regulating, promoting flow of QI and blood, the treatment cholelithiasis has obvious curative effects.
The specific embodiment
Below further describe concrete technical scheme of the present invention, so that those skilled in the art understands the present invention further, and do not consist of its Copyright law.
Embodiment 1, a kind of pharmaceutical composition for the treatment of cholelithiasis, and it is to be made by the raw material of following weight proportion:
Rhizoma Cyperi 20; The Radix Aucklandiae 5;
Radix Curcumae 20; The Radix Paeoniae Alba 5;
Radix Glycyrrhizae Preparata 10; Radix Achyranthis Bidentatae 20;
The Rhizoma Pinelliae 5; Cortex Magnoliae Officinalis 20;
Radix Bupleuri 30; Fructus Gardeniae 10;
During preparation, all raw materials are added water 1000ml boil, when transferring slow fire to and continuing to boil to 800ml medicine juice is poured in the bowl; Add water in the medicine pot and do not have raw material to continue to boil 20 minutes, medicine juice is poured in the bowl; Add water in the medicine pot and do not have raw material to continue to boil 10 minutes, medicine juice is poured in the bowl, the medicine juice of pouring out for three times is mixed stirring evenly, and get final product.
Embodiment 2, a kind of pharmaceutical composition for the treatment of cholelithiasis, and it is to be made by the raw material of following weight proportion:
Rhizoma Cyperi 40; The Radix Aucklandiae 15;
Radix Curcumae 40; The Radix Paeoniae Alba 15;
Radix Glycyrrhizae Preparata 20; Radix Achyranthis Bidentatae 40;
The Rhizoma Pinelliae 15; Cortex Magnoliae Officinalis 40;
Radix Bupleuri 40; Fructus Gardeniae 30;
During preparation, all raw materials are added water 1000ml boil, when transferring slow fire to and continuing to boil to 800ml medicine juice is poured in the bowl; Add water in the medicine pot and do not have raw material to continue to boil 20 minutes, medicine juice is poured in the bowl; Add water in the medicine pot and do not have raw material to continue to boil 10 minutes, medicine juice is poured in the bowl, the medicine juice of pouring out for three times is mixed stirring evenly, and get final product.
Embodiment 3, a kind of pharmaceutical composition for the treatment of cholelithiasis, and it is to be made by the raw material of following weight proportion:
Rhizoma Cyperi 30; The Radix Aucklandiae 10;
Radix Curcumae 30; The Radix Paeoniae Alba 10;
Radix Glycyrrhizae Preparata 15; Radix Achyranthis Bidentatae 30;
The Rhizoma Pinelliae 10; Cortex Magnoliae Officinalis 30;
Radix Bupleuri 350; Fructus Gardeniae 20;
During preparation, all raw materials are added water 1000ml boil, when transferring slow fire to and continuing to boil to 800ml medicine juice is poured in the bowl; Add water in the medicine pot and do not have raw material to continue to boil 20 minutes, medicine juice is poured in the bowl; Add water in the medicine pot and do not have raw material to continue to boil 10 minutes, medicine juice is poured in the bowl, the medicine juice of pouring out for three times is mixed stirring evenly, and get final product.

Claims (2)

1. a pharmaceutical composition for the treatment of cholelithiasis is characterized in that, it is to be made by the raw material of following weight proportion:
Rhizoma Cyperi 20-40; Radix Aucklandiae 5-15;
Radix Curcumae 20-40; Radix Paeoniae Alba 5-15;
Radix Glycyrrhizae Preparata 10-20; Radix Achyranthis Bidentatae 20-40;
Rhizoma Pinelliae 5-15; Cortex Magnoliae Officinalis 20-40;
Radix Bupleuri 30-40; Fructus Gardeniae 10-30;
During preparation, all raw materials are added water 1000ml boil, when transferring slow fire to and continuing to boil to 800ml medicine juice is poured in the bowl; Add water in the medicine pot and do not have raw material to continue to boil 20 minutes, medicine juice is poured in the bowl; Add water in the medicine pot and do not have raw material to continue to boil 10 minutes, medicine juice is poured in the bowl, the medicine juice of pouring out for three times is mixed stirring evenly, and get final product.
2. a kind of pharmaceutical composition for the treatment of cholelithiasis according to claim 1 is characterized in that the weight proportion of each raw material is:
Rhizoma Cyperi 30; The Radix Aucklandiae 10;
Radix Curcumae 30; The Radix Paeoniae Alba 10;
Radix Glycyrrhizae Preparata 15; Radix Achyranthis Bidentatae 30;
The Rhizoma Pinelliae 10; Cortex Magnoliae Officinalis 30;
Radix Bupleuri 350; Fructus Gardeniae 20.
CN 201210467512 2012-11-19 2012-11-19 Pharmaceutical composition for treating gallstone Pending CN103007188A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210467512 CN103007188A (en) 2012-11-19 2012-11-19 Pharmaceutical composition for treating gallstone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210467512 CN103007188A (en) 2012-11-19 2012-11-19 Pharmaceutical composition for treating gallstone

Publications (1)

Publication Number Publication Date
CN103007188A true CN103007188A (en) 2013-04-03

Family

ID=47956652

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210467512 Pending CN103007188A (en) 2012-11-19 2012-11-19 Pharmaceutical composition for treating gallstone

Country Status (1)

Country Link
CN (1) CN103007188A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103933478A (en) * 2014-04-22 2014-07-23 湖州康企药业有限公司 Medicine for treating gall-stone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103933478A (en) * 2014-04-22 2014-07-23 湖州康企药业有限公司 Medicine for treating gall-stone

Similar Documents

Publication Publication Date Title
CN103341004B (en) Chinese medicine composition for treating delayed menstrual cycle
CN102423421A (en) Medicine for treating hypertension
CN102526691A (en) External application plaster for treating dysmenorrhea
CN104435692A (en) Prescription for treating nerve headache and preparation method thereof
CN101041036A (en) Medicine liquid for reducing pain for external application
CN101422530A (en) Traditional Chinese medicine for treating upper right front-tooth pyretic toothache
CN100998722B (en) Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia
CN103100021A (en) Pharmaceutical composition for tonifying spleen and stomach and method for preparing same
CN102134543A (en) Medicinal liquor with effect of conditioning spleen and stomach
CN101829230A (en) Hair anti-dropping and growing lotion
CN103007188A (en) Pharmaceutical composition for treating gallstone
CN104971318A (en) Traditional Chinese medicine preparation for treating cholelithiasis
CN102772606B (en) Traditional Chinese medicine wine for treating sciatica and lumbocrural pain
CN101837111A (en) Medicament for curing proliferation of mammary glands and preparation method thereof
CN104666645A (en) Formula of traditional Chinese medicine for treating freckles
CN100998729A (en) Oral traditional Chinese medicine for treating astriction of deficiency of blood type
CN103520662A (en) Traditional Chinese medicine formula for treating ankylosing spondylitis
CN104873844A (en) Preparation method of health wine with effects of relaxing muscles and tendons and dredging collaterals
CN103736024A (en) Method for preparing medicine for treating dysmenorrhea
CN103656149A (en) Preparation method of traditional Chinese medicine prescription for treating insomnia
CN102283974B (en) Oral liquid for curing female infertility
CN106728060A (en) It is a kind of to treat externally applied ointment of rheumatism and preparation method thereof
CN102038826A (en) Medicament for treating hyperthyroidism
CN101002853A (en) Oral medicine for treating cephalagra type hemidrosis
CN106266929A (en) A kind of blood circulation promoting and blood stasis dispelling life-prolonging pill and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130403